2070009-33-3
Chemical Structure
Lurasidone metabolite 14326-d8
- CAS No.: 2070009-33-3
- Formula:C28H28D8N4O3S
- Molecular Weight:516.72
IUPAC Name: (3aR,4S,5S,7S,7aS)-2-(((1R,2R)-2-((4-(benzo[d]isothiazol-3-yl)piperazin-1-yl-2,2,3,3,5,5,6,6-d8)methyl)cyclohexyl)methyl)-5-hydroxyhexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione
InChIKey: JVTNTCYRWHASTQ-QJKOTDNASA-N
SMILES: O=C([C@]([C@@H]1C[C@H](O)[C@H]2C1)([H])[C@]2([H])C3=O)N3C[C@H]4[C@H](CN(C([2H])([2H])C5([2H])[2H])C([2H])([2H])C([2H])([2H])N5C6=NSC7=C6C=CC=C7)CCCC4
Biological Activity: Lurasidone metabolite 14326-d8 is a deuterium-labeled form of Lurasidone metabolite 14326 (HY-G0002). Lurasidone metabolite 14326 is a minor active metabolite of Lurasidone (HY-B0032A) generated via metabolism by CYP3A4. Lurasidone metabolite 14326 shares similar receptor-binding properties with Lurasidone, acting as an antagonist of the dopamine D2 receptor (dopamine D2 receptor), an antagonist of the serotonin 5-HT2A and 5-HT7 receptors (5-HT2A and 5-HT7 receptor), and a partial agonist of the serotonin 5-HT1A receptor. Lurasidone metabolite 14326 can be used in the research of schizophrenia and bipolar depression[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Lurasidone metabolite 14326-d8 | Lurasidone metabolite 14326-d8 is a deuterium-labeled form of Lurasidone metabolite 14326 (HY-G0002). Lurasidone metabolite 14326 is a minor active metabolite of Lurasidone (HY-B0032A) generated via metabolism by CYP3A4. Lurasidone metabolite 14326 shares similar receptor-binding properties with Lurasidone, acting as an antagonist of the dopamine D2 receptor (dopamine D2 receptor), an antagonist of the serotonin 5-HT2A and 5-HT7 receptors (5-HT2A and 5-HT7 receptor), and a partial agonist of the serotonin 5-HT1A receptor. Lurasidone metabolite 14326 can be used in the research of schizophrenia and bipolar depression. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Lurasidone metabolite 14326 | Lurasidone metabolite 14326 is a minor active metabolite of Lurasidone (HY-B0032A) generated via metabolism by CYP3A4. Lurasidone metabolite 14326 shares similar receptor-binding properties with Lurasidone, acting as an antagonist of the dopamine D2 receptor (dopamine D2 receptor), an antagonist of the serotonin 5-HT2A and 5-HT7 receptors (5-HT2A and 5-HT7 receptor), and a partial agonist of the serotonin 5-HT1A receptor. Lurasidone metabolite 14326 can be used in the research of schizophrenia and bipolar depression. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
